Perrigo To Enter Generic Rx Market; Could Clarinex ANDA Be In Its Sights?
Executive Summary
Perrigo plans to complement its OTC private label business with a move into generic prescription drugs in 2004
You may also be interested in...
Schering OTC Claritin Will Launch In December Without Rx Transition Period
Schering-Plough prescription Claritin availability will not overlap with OTC loratadine once the switched drug becomes available in December
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials